NCT04635657

Brief Summary

The purpose of this prospectively enrolling trial is to assess long-term cognitive outcomes of patients undergoing surgery for resection of a meningioma associated with the frontal and temporal lobes.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Dec 2019

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 10, 2019

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

September 29, 2020

Completed
2 months until next milestone

First Posted

Study publicly available on registry

November 19, 2020

Completed
4.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

October 24, 2023

Status Verified

October 1, 2023

Enrollment Period

5.1 years

First QC Date

September 29, 2020

Last Update Submit

October 22, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Overall cognitive function

    Cognitive function will be compared at baseline and at one year post-operatively.

    12 months

Secondary Outcomes (2)

  • Cognitive function based on surgical approach using Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)

    12 months

  • Cognitive function based on tumor location using Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)

    12 months

Other Outcomes (1)

  • Surgical comorbidities based on quality of life questionnaire PROMIS-29

    12 months

Study Arms (1)

Meningioma Group

This group will include all patients in the study, regardless of location (frontal or temporal lobe) or surgical approach (endoscopic endonasal or craniotomy). Fifty patients will be included in the cohort

Other: Long-term Cognitive testing

Interventions

These patients will undergo their standard of care cognitive testing at baseline, six weeks post-operatively and one year post-operatively.

Meningioma Group

Eligibility Criteria

Age18 Years - 89 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients between 18 years of age and 89 years of age will be eligible for this study. Patients undergoing a resection of a meningioma located in the frontal or temporal lobes via craniotomy or endoscopic endonasal surgery for clinical purposes will be included. Should a patient have a previous surgical removal of a meningioma, they will still be included. However, all patients having undergone previous radiation to the brain, for any reason, will not be included in the study.

You may qualify if:

  • Subject has a meningioma associated with the frontal or temporal lobes
  • Subject is scheduled to undergo open craniotomy or Endoscopic Endonasal surgery
  • Subject is 18 years of age or older
  • The subject must in the investigator's opinion, be psychosocially, mentally, and physically able to fully comply with this protocol including the required follow-up visits, the filling out of required forms, and have the ability to understand and give written informed consent
  • Previous surgery will not exclude the patient as a new baseline cognitive evaluation will occur.

You may not qualify if:

  • Patient is a prisoner
  • Patient is 90 years of age or older
  • Pregnant women
  • Previous radiation to the brain

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ohio State University Wexner Medical Center

Columbus, Ohio, 43210, United States

RECRUITING

MeSH Terms

Conditions

MeningiomaCognitive Dysfunction

Condition Hierarchy (Ancestors)

Neoplasms, Nerve TissueNeoplasms by Histologic TypeNeoplasmsNeoplasms, Vascular TissueMeningeal NeoplasmsCentral Nervous System NeoplasmsNervous System NeoplasmsNeoplasms by SiteNervous System DiseasesCognition DisordersNeurocognitive DisordersMental Disorders

Study Officials

  • Daniel Prevedello, MD

    Ohio State University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Megan Frost, BS

CONTACT

Uchechi Okafor, BS

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

September 29, 2020

First Posted

November 19, 2020

Study Start

December 10, 2019

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

October 24, 2023

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will not share

There will not be sharing of individual participant data with other researchers

Locations